from Reuters: Business News https://ift.tt/2CDx2m3
Sunday, September 9, 2018
Roche faces UK pricing row over multiple sclerosis drug Ocrevus
Roche faces a fresh row over drug pricing in Britain, following a decision by the body responsible for medicine use within the state health service not to approve its drug Ocrevus for treating a highly disabling form of multiple sclerosis (MS).
from Reuters: Business News https://ift.tt/2CDx2m3
from Reuters: Business News https://ift.tt/2CDx2m3
Related Posts:
Loan charge - retrospective tax bills for freelancers- Richer Sounds boss wants 'to do the right thing'
- Pilots 'raised Boeing safety fears' months before Ethiopia crash
- Fears of flying Boeing’s 737 MAX won’t get in way of price conscious ticket shoppers: Reuters/IPSOS poll
- What's the secret of life satisfaction?
0 comments:
Post a Comment